الصفحة الرئيسية>>Peptides>>Adrenomedullin (AM) (22-52), human (22-52-Adrenomedullin (human))

Adrenomedullin (AM) (22-52), human (22-52-Adrenomedullin (human))

رقم الكتالوجGC32615

Adrenomedullin (AM) (22-52) ، بشري (22-52-Adrenomedullin (بشري)) ، نظير أدرينوميدولين مبتور طرفي NH2 ، هو مضاد لمستقبلات الأدرينوميدولين ، كما أنه يعادي مستقبل الببتيد الناتج عن الكالسيتونين (CGRP) في الأوعية الدموية الخلفية سرير القط.

Products are for research use only. Not for human use. We do not sell to patients.

Adrenomedullin (AM) (22-52), human (22-52-Adrenomedullin (human)) التركيب الكيميائي

Cas No.: 159899-65-7

الحجم السعر المخزون الكميّة
500μg
129٫00
متوفر
1mg
220٫00
متوفر
5mg
883٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Adrenomedullin (AM) (22-52), human is an adrenomedullin receptor antagonist, and also antagonizes the calcitonin generelated peptide (CGRP) receptor in the hindlimb vascular bed of the cat.

Adrenomedullin (AM) (22-52), human shows no effect on hindlimb perfusion pressure responses to adrenomedullin (ADM) at 120 nmol. However, Adrenomedullin (AM) (22-52), human selectively and reversibly decreases vasodilator responses to human calcitonin generelated peptide (hCGRP) at 30 nmol, with similar effect to that of CGRP antagonist[1].

[1]. Champion HC, et al. Adrenomedullin-(22-52) antagonizes vasodilator responses to CGRP but not adrenomedullin in the cat. Am J Physiol. 1997 Jan;272(1 Pt 2):R234-42.

مراجعات

Review for Adrenomedullin (AM) (22-52), human (22-52-Adrenomedullin (human))

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Adrenomedullin (AM) (22-52), human (22-52-Adrenomedullin (human))

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.